paxilline has been researched along with Hypertension in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cidad, P; López-López, JR; Miguel-Velado, E; Moreno-Domínguez, A; Pérez-García, MT | 1 |
Bouillier, H; Dagher, G; Renaud, JF; Rücker-Martin, C; Safar, M; Samain, E | 1 |
2 other study(ies) available for paxilline and Hypertension
Article | Year |
---|---|
De novo expression of Kv6.3 contributes to changes in vascular smooth muscle cell excitability in a hypertensive mice strain.
Topics: Animals; Aorta; Cell Line; Gene Expression Profiling; Hypertension; Indoles; Ion Channel Gating; Mesenteric Arteries; Mice; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Shab Potassium Channels; Shaker Superfamily of Potassium Channels; Triterpenes | 2009 |
Effect of extracellular matrix elements on angiotensin II-induced calcium release in vascular smooth muscle cells from normotensive and hypertensive rats.
Topics: Angiotensin II; Animals; Calcium; Cell Cycle; Cells, Cultured; Collagen; Cytoskeletal Proteins; Drug Combinations; Extracellular Matrix Proteins; Fibronectins; Hypertension; Laminin; Male; Muscle, Smooth, Vascular; Paxillin; Phosphoproteins; Proteoglycans; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thapsigargin; Vitronectin | 2001 |